In the future, we are intrigued by the prospect of substantiating our findings through validation in human cancer cell lines associated with hyperactivated IIS or Ras activity, such as cutaneous melanoma and certain types of leukemias, among many other human malignancies [20,21,33]. This evidence concerns the gene SCGB1D4 and cutaneous melanoma.